NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Aruna Bio logo
Aruna Bio, a Georgia pharmaceutical company with a growing Raleigh presence, has been awarded a $4.5 million grant from the National Institutes of Health to support its development of a potential stroke treatment.
Cartoon of the GI tract
Raleigh clinical-stage pharmaceutical developer Innovate Biopharma is merging with Israel-based RDD Pharma to create a new company, 9 Meters Biopharma.
Wake Forest lung-on-a-chip technology
The Wake Forest Institute for Regenerative Medicine has won a $24 million federal grant to model the effects of chlorine gas on human lungs and to develop treatments for chemical injury.
Exela exterior
Two North Carolina life science companies have teamed up to resolve a multi-year, national shortage of an important drug.
Dova logo
Durham-based Dova Pharmaceuticals plans to merge with a Swedish biopharmaceutical company in a deal that could be worth up to $915 million to Dova’s shareholders.
Piedmont ANimal Health logo
Greensboro's Piedmont Animal Health has received a patent for the formulation platform of its long-acting sterile injectable macrolide antibiotics for administration to companion animals and humans.
CHIP table at grad resource fair at UNC
If you’re a life science professional looking to take the next career step, but can’t afford to quit your day job, you may want to consider UNC's new online program to earn a Master of Professional Science degree in biomedical and health informatics.
Eva Garland
Raleigh’s Eva Garland Consulting, LLC has expanded its partnership with the National Institutes of Health, thanks to a newly awarded contract.
Pfizer logo
Pfizer, the international biopharmaceutical giant, is expanding its gene therapy program with the purchase of a Durham property that will become a clinical manufacturing facility.
Guy with flu
NIH has launched a massive effort to develop better flu vaccines, awarding the Duke Human Vaccine Institute three contracts worth up to $400 million over seven years.
CivaTech logo
RTP's CivaTech Oncology has received marketing approval from the FDA for its new CivaDerm skin cancer treatment "bandage."
Ribometrix logo
Durham's Ribometrix, started with funding help from NCBiotech, will partner with Vertex Pharmaceuticals of Boston to discover and develop drug candidates in a deal that could ultimately be worth more than $700 million to Ribometrix.
BioCryst logo
The U.S. Department of Health and Human Services has exercised its option to purchase an additional 10,000 doses of BioCryst Pharmaceutical’s approved antiviral influenza therapy, RAPIVAV.
Funding panel
Knowledge is power. Work smarter not harder. Both principles drove the third annual Informing Innovation 2019 event hosted recently by the Life Science Intelligence team at the North Carolina Biotechnology Center.
Locus logo
Morrisville-based Locus Biosciences, a developer of precision antibacterial therapies, joins companies from the U.S., Belgium, the U.K. and Spain named to the prestigious "Fierce 15" listing of the world's hottest biotech companies.